Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-05-13

FDA Approved: FAMOTIDINE — Supplemental Application (Carlsbad Technology, Inc)

View source ↗

Summary

FDA approved a supplemental application for famotidine (Carlsbad Technology, Inc.), resulting in changes to its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine (famotidine)

Snippet

SUPPL AP for FAMOTIDINE (FAMOTIDINE)